Enzyme Replacement Therapy Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
This tender has closed
The submission deadline for this contract has passed. There may be more active supplies tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"), and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded this contract to Takeda UK Limited worth £6,079,596 on 19 Jul 2024.
Description
Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland:
- NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV®)
- NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase®)
- NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal®)
Additional information
The estimated value(s) of the Framework Agreement referred to in Sections II.1.7 and V.2.4 cover(s) the twenty-four (24) month contract duration and the twelve (12) month extension period of the Framework Agreement.
Awarded supplier
Contact
Identifiers
Explore related tenders
External ID: pcs-ocds-r6ebe6-0000774980 • Added 27 May 2026